Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX: AXPH)

AXPH Cash Flow Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	216.68	216.68	126.43	117.42	117	170.05
Depreciation & Amortization	37.56	37.56	-	23.18	-	-
Other Operating Activities	-64.61	-64.61	-35.09	52.14	-17.57	-30.25
Operating Cash Flow	189.62	189.62	91.34	192.75	99.42	139.8
Operating Cash Flow Growth	-7.85%	107.60%	-52.61%	93.87%	-28.88%	1.44%
Capital Expenditures	-62.22	-62.22	-84.25	-31.85	-119.99	-71.22
Sale of Property, Plant & Equipment	0.56	0.56	1.03	-	0.4	-
Other Investing Activities	13.33	13.33	5.38	5.25	5.97	11.21
Investing Cash Flow	-48.33	-48.33	-77.84	-26.6	-113.62	-60.02
Common Dividends Paid	-81.97	-81.97	-76.94	-64.52	-100.29	-78.08
Financing Cash Flow	-81.97	-81.97	-76.94	-64.52	-100.29	-78.08
Net Cash Flow	59.33	59.33	-63.44	101.63	-114.49	1.7
Free Cash Flow	127.41	127.41	7.09	160.9	-20.57	68.57
Free Cash Flow Growth	-10.13%	1696.05%	-95.59%	-	-	-45.02%
Free Cash Flow Margin	7.21%	7.21%	0.48%	14.63%	-1.86%	6.69%
Free Cash Flow Per Share	25.48	25.48	1.42	32.18	-4.11	11.61
Cash Income Tax Paid	51.65	51.65	46.02	49.3	62.87	44.24
Levered Free Cash Flow	122.74	122.74	-44.18	155.37	-46.87	20.89
Unlevered Free Cash Flow	122.74	122.74	-44.18	155.37	-46.87	20.89
Change in Net Working Capital	19.78	19.78	56.76	-79.95	23.2	46.45

Source: S&P Capital IQ. Standard template. Financial Sources.